16:02 Dec 20
Piramal Pharma Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Piramal Pharma Ltd.
80/100 High Financial Strength
Quality22/100 Expensive Valuation
Valuation63/100 Technically Moderately Bullish
TechnicalSWOT
Strength
12
Weakness
2
Opportunity
1
Threat
0
33.44K
Market Cap (Cr)
737.60
PE Ratio
4.23
Price to Book Ratio
46.86
RSI
0.21 %
Net Profit Margin
Rating Based on 6 Analysts
Buy
100%
Hold
0%
Sell
0%
Buy
Analyst Price Target
The average price target is 237.17 with a high estimate of 310 and low estimate of 176
Current 252.20
Disclaimer:The analysis information is for reference only and does not constitude an investment recommendation
SWOT
Download Our App On:
